Renaissance Technologies
TBIO

Renaissance Technologies’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Renaissance Technologies’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,530
Closed -$11K – 4175
2023
Q4 		$11K Buy
+1,530
New +$17K ﹤0.01% 3636
2023
Q3 		– Sell
-5,128
Closed -$146K – 4215
2023
Q2 		$146K Sell
5,128
-172
-3% -$6.87K ﹤0.01% 3373
2023
Q1 		$296K Buy
5,300
+794
+18% +$28.1K ﹤0.01% 3133
2022
Q4 		$97K Sell
4,506
-3,561
-44% -$96.8K ﹤0.01% 3630
2022
Q3 		$241K Buy
+8,067
New +$284K ﹤0.01% 3302

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Renaissance Technologies's TBIO Position: Q1 2024 in Review

Renaissance Technologies sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q1 2024, closing a stake of 1,530 shares — an estimated $11K sold.

Renaissance Technologies first reported a position in TBIO in Q3 2022 and held it in 5 quarters. The position peaked at $296K in Q1 2023. 20 funds tracked by Wall St. Rank hold TBIO as of Q1 2024.

  • Renaissance Technologies reported no remaining Telesis Bio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Renaissance Technologies sold 1,530 Telesis Bio, Inc. Common Stock shares in Q1 2024, an estimated $11K.
  • Renaissance Technologies first reported a position in Telesis Bio, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
  • Renaissance Technologies's Telesis Bio, Inc. Common Stock position peaked at $296K in Q1 2023.
  • 20 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.